GK
GILD icon

Graney & King’s Gilead Sciences GILD Stock Holding History

Graney & King’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11K Hold
87
– – ﹤0.01% 248
2026
Q1 		$12.1K Hold
87
– – 0.01% 228
2025
Q4 		$10.6K Hold
87
– – 0.01% 235
2025
Q3 		$9.62K Buy
87
+1
+1% +$114 0.01% 233
2025
Q2 		$9.55K Buy
86
+1
+1% +$106 0.01% 221
2025
Q1 		$9.58K Hold
85
– – 0.01% 219
2024
Q4 		$7.84K Buy
+85
New +$7.65K 0.01% 221

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Graney & King's GILD Position: Q2 2026 in Review

Graney & King held its Gilead Sciences (GILD) position steady in Q2 2026 at 87 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #248.

Graney & King first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $12.1K in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Graney & King held 87 shares of Gilead Sciences worth $11K as of Q2 2026.
  • Graney & King left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up ﹤0.01% of Graney & King's portfolio in Q2 2026, its #248 holding.
  • Graney & King first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Graney & King's Gilead Sciences position peaked at $12.1K in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Graney & King's 13F filing for Q2 2026, filed 7 Aug 2026.